Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study

被引:17
作者
Shinohara, Danielle Rosani [1 ]
Menegucci, Thatiany Cevallos [1 ]
Fedrigo, Nayara Helisandra [1 ]
Migliorini, Leticia Busato [1 ]
Carrara-Marroni, Floristher Elaine [2 ]
dos Anjos, Marcia Maria [1 ]
Cardoso, Celso Luiz [1 ]
Belini Nishiyama, Sheila Alexandra [1 ]
Bronharo Tognim, Maria Cristina [1 ]
机构
[1] Univ Estadual Maringa, Ave Colombo 5790, BR-87020900 Maringa, Parana, Brazil
[2] Univ Estadual Londrina, Rodovia Celso Garcia Cid,Pr 445 Km 380, BR-86057970 Londrina, Parana, Brazil
关键词
Acinetobacter baumannii; polymyxin B; vancomycin; drug combinations; MUTANT PREVENTION CONCENTRATIONS; COLISTIN-RESISTANT; COMBINATION; STRAINS; AGENTS;
D O I
10.1099/jmm.0.000920
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Purpose. The effect of a combination of polymyxin B (PMB) and vancomycin (VAN) was assessed against six Acinetobacter baumannii clinical isolates belonging to six different clusters (three PMB-susceptible and three PMB-resistant). Methodology. The synergistic effect of the PMB-VAN combination was determined with the checkerboard, time-kill, disk-diffusion and M.I.C.Evaluator assays. PMB-resistance was investigated with mcr-1 gene amplification and a mutant frequency assay. Results. In the checkerboard assay, all PMB-resistant isolates showed a synergistic effect. The time-kill assay demonstrated that the PMB-VAN combination had a bactericidal effect at 24 h against isolates with a high mutant rate for PMB, suggesting that this combination may block the hypermutation of some isolates. No antagonism was detected. All PMB-resistant isolates also showed synergism in the disk-diffusion test, and a significant decrease in VAN MICs in the M.I.C.Evaluator assay. Conclusion. Our findings indicate that the PMB-VAN combination has a synergistic effect on A. baumannii, especially against PMB-resistant isolates.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 34 条
  • [1] In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii
    Bae, Seongman
    Kim, Min-Chul
    Park, Su-Jin
    Kim, Hee Sueng
    Sung, Heungsup
    Kim, Mi-Na
    Kim, Sung-Han
    Lee, Sang-Oh
    Choi, Sang-Ho
    Woo, Jun Hee
    Kim, Yang Soo
    Chong, Yong Pil
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6774 - 6779
  • [2] Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae
    Blondeau, JM
    Zhao, XL
    Hansen, G
    Drlica, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 433 - 438
  • [3] A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii
    Boll, Joseph M.
    Crofts, Alexander A.
    Peters, Katharina
    Cattoir, Vincent
    Vollmer, Waldemar
    Davies, Bryan W.
    Trent, M. Stephen
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (41) : E6228 - E6237
  • [4] Polymyxin B versus colistin: an update
    Cai, Yiying
    Lee, Winnie
    Kwa, Andrea L.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (12) : 1481 - 1497
  • [5] Clinical and Laboratory Standards Institute, 2018, M100 CLIN LAB STAND, V12th
  • [6] Clinical and Laboratory Standards Institute, 2015, M07A10 CLIN LAB STAN
  • [7] Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae:: review and bench guide
    Drieux, L.
    Brossier, F.
    Sougakoff, W.
    Jarlier, V.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 90 - 103
  • [8] Comparison of Methods To Test Antibiotic Combinations against Heterogeneous Populations of Multiresistant Pseudomonas aeruginosa from Patients with Acute Infective Exacerbations in Cystic Fibrosis
    Foweraker, Juliet E.
    Laughton, Christian R.
    Brown, Derek F.
    Bilton, Diana
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4809 - 4815
  • [9] Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
    Garnacho-Montero, Jose
    Amaya-Villar, Rosario
    Gutierrez-Pizarraya, Antonio
    Espejo-Gutierrez de Tena, Esther
    Luisa Artero-Gonzalez, M.
    Corcia-Palomo, Yael
    Bautista-Paloma, Javier
    [J]. CHEMOTHERAPY, 2013, 59 (03) : 225 - 231
  • [10] Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii
    Gordon, N. C.
    Png, K.
    Wareham, D. W.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (12) : 5316 - 5322